Related Experiment Video
Updated: Aug 25, 2025
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
7.7K
Colloidal Polyelectrolyte Complexes from Hyaluronic Acid: Preparation and Biomedical Applications
1Normandie Univ, UNIROUEN, INSA Rouen, CNRS, PBS UMR 6270, Rouen, 76000, France.
Small (Weinheim an Der Bergstrasse, Germany)
|October 19, 2022
Summary
Hyaluronic acid (HA) and polycations form colloidal polyelectrolyte complexes (PECs) for advanced biomedical uses. These green-chemistry derived materials offer excellent biocompatibility and targeting for drug delivery and bioimaging applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Polymer Chemistry
Background:
- Hyaluronic acid (HA) is a biocompatible polysaccharide widely used in biomedicine.
- Polyelectrolyte complexes (PECs) can be formed via electrostatic interactions between HA and polycations.
- Colloidal HA-based PECs leverage nanomedicine and green chemistry principles.
Purpose of the Study:
- To provide a comprehensive review of colloidal HA-polycation PECs.
- To cover fundamental preparation aspects and diverse biomedical applications.
- To highlight their potential as advanced nanocarriers and multifunctional platforms.
Main Methods:
- Review of literature on HA-polycation PEC formation.
- Analysis of self-assembly mechanisms driven by electrostatic interactions.
- Compilation of applications in drug delivery, nucleic acid delivery, protein delivery, and bioimaging.
Main Results:
- Colloidal HA-based PECs are synthesized through simple, rapid, and green processes.
- These PECs exhibit high biocompatibility, biodegradability, and biological targeting.
- HA-PECs demonstrate significant potential as nanocarriers for various therapeutic and diagnostic agents.
Conclusions:
- Colloidal HA-polycation PECs represent high-performance materials for biomedical applications.
- Their inherent properties and facile preparation make them attractive for nanomedicine.
- Further research into HA-based PECs will drive innovation in drug delivery and bioimaging.
